Two Sigma Advisers’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-267,500
Closed -$361K 1471
2025
Q4
$361K Buy
+267,500
New +$381K ﹤0.01% 1913
2024
Q3
Sell
-26,000
Closed -$40.3K 2451
2024
Q2
$40.3K Buy
+26,000
New +$40.5K ﹤0.01% 2376
2023
Q1
Sell
-43,200
Closed -$56.2K 2707
2022
Q4
$56.2K Buy
+43,200
New +$67.3K ﹤0.01% 2354
2020
Q1
Sell
-21,637
Closed -$11K 2539
2019
Q4
$11K Buy
+21,637
New +$21.5K ﹤0.01% 2333
2019
Q2
Sell
-297
Closed -$2K 2409
2019
Q1
$2K Buy
297
+42
+16% +$359 ﹤0.01% 2275
2018
Q4
$1K Buy
+255
New +$8.13K ﹤0.01% 2334

Other funds holding OCGN

Two Sigma Advisers's OCGN Position: Q1 2026 in Review

Two Sigma Advisers sold out of Ocugen (OCGN) in Q1 2026, closing a stake of 267,500 shares — an estimated $361K sold.

Two Sigma Advisers first reported a position in OCGN in Q4 2018 and held it in 6 quarters. The position peaked at $361K in Q4 2025. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

  • Two Sigma Advisers reported no remaining Ocugen position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 267,500 Ocugen shares in Q1 2026, an estimated $361K.
  • Two Sigma Advisers first reported a position in Ocugen in Q4 2018 and held it in 6 quarters.
  • Two Sigma Advisers's Ocugen position peaked at $361K in Q4 2025.
  • 137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.